| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 0 | 89.919 | 94.962 | 74.253 |
| Total Income - EUR | - | - | - | 0 | 0 | 0 | 0 | 106.057 | 104.209 | 74.438 |
| Total Expenses - EUR | - | - | - | 27 | 0 | 0 | 0 | 87.835 | 91.574 | 82.974 |
| Gross Profit/Loss - EUR | - | - | - | -27 | 0 | 0 | 0 | 18.222 | 12.635 | -8.536 |
| Net Profit/Loss - EUR | - | - | - | -27 | 0 | 0 | 0 | 17.457 | 11.703 | -8.940 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 4 | 3 | 3 |
Check the financial reports for the company - Danilu Cofe Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 47.235 | 38.351 | 38.226 |
| Current Assets | - | - | - | 43 | 0 | 0 | 0 | 9.902 | 20.582 | 19.787 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 5.456 | 12.146 | 8.077 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 2.498 | 5.102 | 3.904 |
| Cash | - | - | - | 43 | 0 | 0 | 0 | 1.948 | 3.334 | 7.806 |
| Shareholders Funds | - | - | - | 16 | 0 | 0 | 0 | 25.483 | 28.359 | 15.851 |
| Social Capital | - | - | - | 43 | 0 | 0 | 0 | 0 | 40 | 40 |
| Debts | - | - | - | 27 | 0 | 0 | 0 | 22.519 | 30.609 | 42.558 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 9.135 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Danilu Cofe Bio S.r.l.